» Authors » Minna Kiviniemi

Minna Kiviniemi

Explore the profile of Minna Kiviniemi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 157
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ilonen J, Kiviniemi M, El-Amir M, Nygard L, Harkonen T, Lempainen J, et al.
Diabetes . 2023 Nov; 73(2):306-311. PMID: 37934957
Article Highlights:
2.
Ilonen J, Laine A, Kiviniemi M, Harkonen T, Lempainen J, Knip M
Pediatr Diabetes . 2022 Apr; 23(6):693-702. PMID: 35403376
Objectives: We aimed to further characterize demography and genetic associations of type 1 diabetes "endotypes" defined by the first appearing islet specific autoantibodies. Research Design And Methods: We analyzed 3277...
3.
Nygard L, Laine A, Kiviniemi M, Toppari J, Harkonen T, Knip M, et al.
Hum Immunol . 2021 Jul; 82(12):912-916. PMID: 34311991
Genes in the HLA class II region include the most important inherited risk factors for type 1 diabetes (T1D) although also polymorphisms outside the HLA region modulate the predisposition to...
4.
Mikk M, Pfeiffer S, Kiviniemi M, Laine A, Lempainen J, Harkonen T, et al.
Pediatr Diabetes . 2020 Jul; 21(7):1218-1226. PMID: 32613719
Objective: We aimed to clarify the association of various HLA risk alleles with different types of autoantibodies initiating islet specific autoimmunity. Methods: Follow-up cohorts from the Finnish Type 1 Diabetes...
5.
Koskinen M, Mikk M, Laine A, Lempainen J, Loyttyniemi E, Vahasalo P, et al.
Diabetes . 2019 Oct; 69(1):12-19. PMID: 31591105
A declining first-phase insulin response (FPIR) is associated with positivity for multiple islet autoantibodies, irrespective of class II HLA DR-DQ genotype. We examined the associations of FPIR with genetic variants...
6.
Bauer W, Veijola R, Lempainen J, Kiviniemi M, Harkonen T, Toppari J, et al.
J Clin Endocrinol Metab . 2019 May; 104(10):4521-4530. PMID: 31120497
Context: Children with initial autoantibodies to either insulin (IAA) or glutamic acid decarboxylase (GADA) differ in peak age of seroconversion and have different type 1 diabetes (T1D) risk gene associations,...
7.
Koskinen M, Lempainen J, Loyttyniemi E, Helminen O, Hekkala A, Harkonen T, et al.
J Clin Endocrinol Metab . 2018 Jan; 103(8):2870-2878. PMID: 29300921
Context: A declining first-phase insulin response (FPIR) is characteristic of the disease process leading to clinical type 1 diabetes. It is not known whether reduced FPIR depends on class II...
8.
El-Amir M, El-Feky M, Laine A, Harkonen T, El-Badawy O, Eltayeb A, et al.
Diabetes Metab Res Rev . 2014 Sep; 31(3):287-94. PMID: 25256132
Background: The study aimed to define the frequencies of type 1 diabetes-associated gene polymorphisms and their associations with various diabetes-associated autoantibodies in Egyptian children. Methods: One hundred and one children...
9.
Lehmusvuori A, Kiviniemi M, Ilonen J, Soukka T
Anal Biochem . 2014 Aug; 465:6-11. PMID: 25120130
Genotyping in closed tube is commonly performed using polymerase chain reaction (PCR) amplification and allele-specific oligonucleotide probes using fluorescence resonance energy transfer (FRET). Here we introduce a homogeneous human leukocyte...
10.
Lipponen K, Gombos Z, Kiviniemi M, Siljander H, Lempainen J, Hermann R, et al.
Diabetes . 2010 Aug; 59(12):3253-6. PMID: 20739684
Objective: Class II alleles define the main HLA effect on type 1 diabetes, but there is an independent effect of certain class I alleles. Class II and class I molecules...